InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the complete record of transactions filed by Doogan Declan, Director. Insider active across 2 companies, notably Tenax Therapeutics, INC.. In total, 12 disclosures have been recorded. Total volume traded: €4.2m. The latest transaction was filed on 11 June 2020 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations12 total
€147,4072,464 shares@ €59.82440.011% mcap6.6% of flow
Common Shares
SEC:0001562180-22-001435·
€668,07211,706 shares@ €57.07090.051% mcap29.7% of flow
Common Shares
SEC:0001562180-22-001434·
€147,4072,464 shares@ €59.82440.011% mcap3.3% of flow
Common Shares
SEC:0001562180-22-001435:0·
€668,07211,706 shares@ €57.07090.051% mcap14.9% of flow
Common Shares
SEC:0001562180-22-001434:0·
€1m13,026 shares@ €99.52870.098% mcap57.7% of flow
Common Shares
SEC:0001562180-21-007370·
€1m13,026 shares@ €99.52870.098% mcap28.9% of flow
Common Shares
SEC:0001562180-21-007370:0·
€134,166250,000 shares@ €0.53670.010% mcap6.0% of flow
Common Shares
SEC:0001562180-21-007138·
€134,166250,000 shares@ €0.53670.010% mcap3.0% of flow
Common Shares
SEC:0001562180-21-007138:0·
0567,871 shares0
Common Stock
SEC:0001654954-21-008766·
0567,871 shares0
Common Stock
SEC:0001654954-21-008766:0·
3,070,000 shares
Common Stock
SEC:0001654954-21-006925·
3,070,000 shares
Common Stock
SEC:0001654954-21-006925:0·
12 of 12 declarations
About Doogan Declan
Declan Doogan serves as a Director at TENAX THERAPEUTICS, INC. and Biohaven Pharmaceutical Holding Co Ltd. He brings his expertise in corporate governance and strategy, contributing to the oversight and direction of these companies' activities. His experience in the pharmaceutical sector enables him to play a crucial role in strategic decision-making.
